<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Medical Xpress news tagged with:pde4</title>
            <link>https://medicalxpress.com/</link>
            <language>en-us</language> 
            <description>Medical Xpress internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

                            <item>
                    <title>New drug compound could tackle major life-limiting kidney disease</title>
                    <description>Scientists from the University of Sheffield are part of an international collaboration to develop a new class of drugs to treat a common genetic kidney disease which is a major cause of kidney failure.</description>
                    <link>https://medicalxpress.com/news/2019-06-drug-compound-tackle-major-life-limiting.html</link>
                    <category></category>
                    <pubDate>Tue, 18 Jun 2019 09:06:31 EDT</pubDate>
                    <guid isPermaLink="false">news480067583</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/newdrugcompo.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New study uncovers probable mechanism underlying resveratrol activity</title>
                    <description>National Institutes of Health researchers and their colleagues have identified how resveratrol, a naturally occurring chemical found in red wine and other plant products, may confer its health benefits. The authors present evidence that resveratrol does not directly activate sirtuin 1, a protein associated with aging. Rather, the authors found that resveratrol inhibits certain types of proteins known as phosphodiesterases (PDEs), enzymes that help regulate cell energy.</description>
                    <link>https://medicalxpress.com/news/2012-02-uncovers-probable-mechanism-underlying-resveratrol.html</link>
                    <category></category>
                    <pubDate>Thu, 02 Feb 2012 12:00:10 EST</pubDate>
                    <guid isPermaLink="false">news247402648</guid>
                                    </item>
                            <item>
                    <title>Phosphodiesterase 4 inhibitors have only marginal benefits for people with COPD</title>
                    <description>Giving patients with chronic obstructive pulmonary disease (COPD) newly available oral phosphodiesterase 4 (PDE4) inhibitors, roflumilast or cilomilast, improves lung function and reduces the likelihood of a flareup, but does not increase general quality of life. These are the findings of a new systematic review by Cochrane researchers.</description>
                    <link>https://medicalxpress.com/news/2011-05-phosphodiesterase-inhibitors-marginal-benefits-people.html</link>
                    <category></category>
                    <pubDate>Wed, 11 May 2011 04:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news224305072</guid>
                                    </item>
                    </channel>
</rss>
